The prostate health index (PHI) is a blood test that more accurately assesses the risk of prostate cancer than a traditional PSA test. The PHI combines three different PSA tests to create one risk ...

To the Editor: In the BARCODE1 study, McHugh et al. (April 10 issue) 1 assessed the use of a polygenic risk score in prostate cancer screening, concluding that more clinically significant cases were ...

CHICAGO — Ten years after major changes in the recommendation for prostate cancer screening, a new analysis finds a sharp increase in advanced and terminal cases of the disease. The study highlights ...

Consider this a PSA about PSA. Prostate cancer is the most common cancer in US men, excluding skin cancer, and the second-leading cause of male cancer deaths, after lung cancer. One in 6 men will be ...

ArteraAI Prostate is now an FDA-regulated software (as a medical device) to estimate long-term outcomes and predict the benefit of hormone therapy for individual patients with localized prostate ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." FORMER PRESIDENT JOSEPH R. Biden has been diagnosed with Stage 4 prostate cancer, his office announced ...